Valuation (29%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.45 | N/A |
| PEG Ratio (TTM) | 0.21 | N/A |
| P/S Ratio (TTM) | 3.29 | N/A |
| P/B Ratio (TTM) | 1.60 | N/A |
| P/FCF Ratio (TTM) | -9.87 | N/A |
| Price to 5YR AVG Earnings Ratio | -3.38 | N/A |
| Price to 5YR AVG FCF Ratio | -13.19 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -14.31% | N/A |
| ROE (TTM) | -25.25% | N/A |
| Net Profit Margin (TTM) | -49.88% | N/A |
| ROIC 5YR AVG | -36.04% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -50.34% | -1,235.75% | -739.77% |
| Revenue | -1.58% | 30.91% | 64.60% |
| Net Income | -56.06% | -900.59% | -550.09% |
| Cash Flow | -9.37% | -909.26% | -560.26% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.39 | N/A |
| Quick Ratio (TTM) | 1.87 | N/A |
| D/E Ratio (TTM) | 0.39 | N/A |
| Interest Coverage (TTM) | -18.13 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 0.70 | N/A |
| LTL to 5YR AVG FCF | -2.93 | N/A |
| Shares Outstanding Growth 5YR AVG | 830.00% | N/A |